Skip to main content
ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
10.90
-0.03 (-0.27%)
At close: Apr 28, 2026, 4:00 PM EDT
10.88
-0.02 (-0.18%)
After-hours: Apr 28, 2026, 7:32 PM EDT

ADMA Biologics Revenue

In the year 2025, ADMA Biologics had annual revenue of $510.17M with 19.63% growth. ADMA Biologics had revenue of $139.16M in the quarter ending December 31, 2025, with 18.39% growth.

Revenue (ttm)
$510.17M
Revenue Growth
+19.63%
P/S Ratio
4.96
Revenue / Employee
$788,521
Employees
647
Market Cap
2.53B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025510.17M83.72M19.63%
Dec 31, 2024426.45M168.24M65.15%
Dec 31, 2023258.22M104.13M67.59%
Dec 31, 2022154.08M73.14M90.36%
Dec 31, 202180.94M38.72M91.72%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Zai Lab 460.16M
Tarsus Pharmaceuticals 451.36M
IDEAYA Biosciences 218.71M
Soleno Therapeutics 190.41M
Beam Therapeutics 139.74M
Immunome 6.94M
Celldex Therapeutics 1.55M
Revenue Rankings

ADMA News

More News